Substituted azole acid derivatives useful as antidiabetic and antiobesity agents and method

Details for Australian Patent Application No. 2002259306 (hide)

Owner Bristol-Myers Squibb Company

Inventors Zhang, Hao; Hariharan, Narayanan; Cheng, Peter T.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2002259306

PCT Pub. Number WO2002/096358

Priority 60/294,380 30.05.01 US

Filing date 23 May 2002

Wipo publication date 9 December 2002

Acceptance publication date 8 February 2007

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/137 (2006.01) - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/138 (2006.01) - Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

A61K 31/192 (2006.01)

A61K 31/198 (2006.01)

A61K 31/216 (2006.01)

A61K 31/22 (2006.01)

A61K 31/277 (2006.01)

A61K 31/357 (2006.01) - having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel

A61K 31/365 (2006.01) - Lactones

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

A61K 31/401 (2006.01) - Proline

A61K 31/403 (2006.01) - condensed with carbocyclic rings, e.g. carbazole

A61K 31/4035 (2006.01)

A61K 31/404 (2006.01)

A61K 31/41 (2006.01) - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61K 31/4168 (2006.01)

A61K 31/4178 (2006.01)

A61K 31/4184 (2006.01)

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/4365

Event Publications

8 May 2003 Application Open to Public Inspection

  Published as AU-B-2002259306

8 February 2007 Application Accepted

  Published as AU-B-2002259306

7 June 2007 Standard Patent Sealed

16 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002259307-A HIGH VOLTAGE CONVERTER SYSTEM

2002259305-HIGH AFFINITY LIGAND FOR p75 NEUROTROPHIN RECEPTOR